Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.98B
Enterprise Value2.83B
P/E Ratio151.34
PEG Ratio3.15
Price/Sales Ratio7.69
Price/Book Ratio3.23
Enterprise/Revenue7.25
Enterprise/EBITDA88.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.05
Operating Margin0.03
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.02

Income Statement

Revenue334.41M
Revenue/Share2.8
Gross Profit140.13M
EBITDA37.34M
Net Income16.49M
Diluted EPS0.14

Balance Sheet

Total Cash228.95M
Total Cash/Share1.89
Total Debt0
Total Debt/Equity0
Current Ratio4
Book Value Per Share6.65

Price History

52-Week Change-2.32
52-Week High42.25
52-Week Low17.75
Moving Average 50 Days21.93
Moving Average 200 Days26.1

Statistics

Average Volume2.61M
Shares Outstanding121.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.13
Trailing Annual Dividend Yield0.6
Payout Ratio2.04
Last Split Factor13:10
Last Split DateMay 11, 2023
AD